Tufts Medical Center - Barbara H. McGovern, MD

Telephone:

Email:

Tufts Medical Center:
617-971-3621

bmcgovern@tufts-nemc.org

Barbara Hedgis McGovern, M.D.

Titles

Associate Professor of Medicine
Tufts University School of Medicine
Division of Infectious Diseases

Lemuel Shattuck Hospital
Director, HIV/HCV clinic

Education Background

1988 M.D. Albert Einstein College of Medicine

1988-89 Internship in Medicine, New England Medical Center, Boston, MA

1989-91 Residency in Medicine, New England Medical Center, Boston, MA

1992-95 Fellowship in Infectious Diseases, New England Medical Center

Research Interests

Acute hepatitis C infection

Clinical Interests

Acute hepatitis C infection
HIV/Hepatitis C coinfection
Drug toxicity

Ongoing Projects

Clinical studies of acute hepatitis C infection in Injection drug users

Honors and Awards

1990 Two successive Clinical Teaching Awards from 1990 and 1991 graduating classes of Tufts University School of Medicine

1996 St. Luke’s Award for outstanding work in medical education
Department of Medicine, St. Elizabeth’s Medical Center

2002 Ray of Hope Award: Presented by Ruah’s House for dedicated work with incarcerated HIV-infected women in MCI Framingham since 1998

2005 Award for teaching excellence from Primary Care Residency Program, Massachusetts General Hospital

Recent Publications

1. Soriano V, Rockstroh J, Puoti M, Barreiro P, McGovern, B. Antiretroviral therapy and hepatotoxicity. AIDS 2008; 22:1-13.

2. McGovern, B. Hepatitis B Coinfection in HIV-infected patients: Epidemiology, natural history of disease and immunization Antiviral Therapy 2007;12 Suppl 3:H3-13.

3. McGovern, BH. A golden opportunity: The treatment of hepatitis C in HIV-infected inmates. Journal of Addictive Diseases 2008; 27:69-73.

4. McGovern, B. Hepatitis C in the HIV-infected Patient. J Acquired Immunodeficiency Syndromes 2007;45:S57-S65.

5. McGovern BH, Birch CE, Zaman MT, Bica I, Stone D, Quirk, JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, and Gandhi RT. Managing symptomatic drug-induced liver injury in HIV/Hepatitis C coinfected patients: a role for interferon. Clinical Infectious Diseases 2007;45:1386-1392.

6. McGovern B, Golan Y, Pratt D, et al. The impact of advanced liver disease on T-cell subsets. Clin Infect Dis 2007; 44:431 (with editorial commentary by Raj Gandhi).

7. McGovern B, Ditelberg J, Taylor L, et al. Hepatic steatosis is associated with fibrosis, nucleoside analog use and hepatitis C genotype 3 infection in HIV-seropositive patients Clin Infect Dis 2006; 43:365-72 (with editorial commentary by Andrew Talal).

8. McGovern B, Wurcel A, Kim, A, et al. Acute hepatitis C in incarcerated patients 2006; Clin Infect Dis 2006; 42:1663-1670 (with editorial commentary by David Thomas).

9. McGovern B, Fiore, J, Wurcel, A, et al. Treatment of hepatitis C in incarcerated HIV-infected patients. Clinical Infectious Diseases 2005; 41:S56-62. (with editorial commentary by David Thomas).

10. McGovern, B. Hepatic safety and HAART. Journal of the International Association of Physicians in AIDS Care (JIAPAC) 2004; 3(2):S23-40.

11. McGovern, B. Invited Editorial Commentary: What Drives HBV Related Hepatic Flares? Virus, T cells – or a Bit of Both? Clin Infect Dis; 2004: 39(1):133-135.